Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $13.9000 (-7.46%) ($12.7100 - $15.3300) on Wed. Mar. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.21% (three month average) | RSI | 26 | Latest Price | $13.9000(-7.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -5.2% a day on average for past five trading days. | Weekly Trend | HALO declines -12% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(54%) IBB(53%) IWM(50%) ARKG(48%) IWC(48%) | Factors Impacting HALO price | HALO will decline at least -1.605% in a week (0% probabilities). VIXM(-37%) VXX(-19%) UUP(-8%) TLT(-2%) TBT(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.605% (StdDev 3.21%) | Hourly BBV | 0 () | Intraday Trend | -3.7% | | | |
|
1 - 5 Day Possible Target | $-4.3(-130.94%) | Resistance Level | $18.92 | 5 Day Moving Average | $15.6(-10.9%) | 10 Day Moving Average | $17.25(-19.42%) | 20 Day Moving Average | $18.92(-26.53%) | To recent high | -36.3% | To recent low | 0% | Market Cap | $1.9b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |